3-Bromo-1-(4-methoxybenzyl)piperidine-2,6-dione

Catalog No. :
ACVFWD784
CAS No. :
2300100-12-1
Molecular Formula :
C13H14BrNO3
Molecular Weight :
312.16

IUPAC Name:3-bromo-1-(4-methoxybenzyl)piperidine-2,6-dione

3-Bromo-1-(4-methoxybenzyl)piperidine-2,6-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$131.00Login to see priceIn stockInquiry
5g95%$422.00Login to see priceIn stockInquiry
25g95%$1196.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-1-(4-methoxybenzyl)piperidine-2,6-dione
IUPAC Name3-bromo-1-(4-methoxybenzyl)piperidine-2,6-dione
MDL No.MFCD34706395
Molecular FormulaC13H14BrNO3
Molecular Weight312.16
SMILESO=C(C(Br)CC1)N(CC2=CC=C(OC)C=C2)C1=O
InChI KeyMJOSHFWNKMJZEF-UHFFFAOYSA-N
Synonym2,6-Piperidinedione, 3-bromo-1-[(4-methoxyphenyl)methyl]-;3-Bromo-1-(4-methoxybenzyl)piperidine-2,6-dione;3-bromo-1-[(4-methoxyphenyl)methyl]piperidine-2,6-dione
CAS No.2300100-12-1

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACVFWD784 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMXYO163 route compound structure diagram
    ACMXYO16362595-74-8 In Stock
  4. Then
  5. ACVFWD784 route product structure diagram
    ACVFWD7842300100-12-1 In Stock
Inquiry

2. ACVFWD784 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMXYO163 route compound structure diagram
    ACMXYO16362595-74-8 In Stock
  4. Then
  5. ACVFWD784 route product structure diagram
    ACVFWD7842300100-12-1 In Stock
Inquiry

Comments (0)